Total Expert and The Baldwin Group Partner at the 2025 Medicarians Conference to Reimagine Medicare Marketing
Total Expert, the FinServ leader in consumer engagement software, and The Baldwin Group, a leading insurance brokerage firm, are joining forces to showcase compliant marketing automation solutions at the 2025 Medicarians Conference. The conference will take place in Las Vegas from March 31 to April 2, 2025.
Through this collaboration, Total Expert and The Baldwin Group will provide Medicare agents with tools to create comprehensive member engagement Journeys that automate communication and enhance the member experience. Additionally, Medicare marketers who use Salesforce can interact directly with their contacts using the Total Expert for Salesforce integration.
'The complexity of the Medicare market has increased dramatically, with the average beneficiary now able to choose from an average of 43 different Medicare Advantage plans —double the options available in 2018,' said Joe Welu, CEO of Total Expert. 'As competition intensifies, our mission is to equip insurance agents with the resources to differentiate themselves and better connect with their customers. Our collaboration with The Baldwin Group reflects our commitment to enhancing agent capabilities in this evolving landscape.'
At the Medicarians Conference, agents will have firsthand opportunities to experience purpose-built solutions from The Baldwin Group and Total Expert. The partnering organizations will demonstrate how agents can use the combined strength of these tools to immediately improve their outreach goals—like increased efficiency and member engagement—using a modern communication platform.
'We understand the challenges agents face in today's market,' said Blake McCoy, Medicare Executive Director of The Baldwin Group. 'Total Expert has a proven track record as a trusted marketing and lead generation solution. That's why we're proud to continue building our partnership with Total Expert and bringing tailored solutions that streamline operations and empower agents to reach and better serve Medicare members.'
How Total Expert and The Baldwin Group help agents take their marketing to the next level:
The Baldwin Group Supports Independent Insurance Agents:
Field Marketing Organizations (FMOs) like The Baldwin Group help independent insurance agents market and sell Medicare plans.
The Baldwin Group provides agents with valuable tools, expert advice, and new contract opportunities to grow their businesses.
Total Expert provides the marketing hub for The Baldwin Group to scale their robust offering for their Agents.
Benefits for Agents:
Agents can improve member retention by using advanced marketing tools that keep the Agents in front of their customers.
Agents can strengthen their local marketing efforts, connecting more effectively with members and prospects.
Agents can manage a higher volume of deals, enhancing their overall productivity and success.
Agents get access to personalized agency grade marketing collateral and libraries all in a single platform.
'As the Medicare landscape continues to evolve, our joint efforts will ensure that agents have the resources they need to thrive in this competitive market and win members for life,' Welu said. 'We aim to simplify the process of connecting agents, agencies, carriers and healthcare providers into one cohesive network. This helps agents stay top-of-mind for their clients and fosters meaningful, long-term relationships.'
Additional information about Total Expert is available at totalexpert.com.
About Total Expert
Total Expert is the purpose-built customer engagement platform trusted by more than 200 financial enterprises. Total Expert unifies data, marketing, sales, and compliance solutions to deliver the perfect customer journey across every financial milestone—in any market. Total Expert turns customer insights into actions that increase loyalty and drive growth for modern banks, lenders, credit unions, and insurance companies. Total Expert is now available for purchase on the AWS Marketplace and Salesforce AppExchange.
The Baldwin Group is an insurance brokerage firm striving to find clients the best personal insurance coverage for property, vehicle, umbrella, small business, life, and Medicare. We offer coverage from some of the most trusted names in insurance today. Based on our clients' budget and specific insurance needs, our agents provide expertise on which option fits them best.
Tyler Coleman
SOURCE: Total Expert
Copyright Business Wire 2025.
PUB: 03/19/2025 09:00 AM/DISC: 03/19/2025 09:03 AM
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) resulting from allegations that GeneDx may have issued materially misleading business information to the investing public. SO WHAT: If you purchased GeneDx securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT TO DO NEXT: To join the prospective class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. WHAT IS THIS ABOUT: On February 5, 2025, Grizzly Research published a report entitled 'Insiders Attest that GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud.' Grizzly stated that GeneDx's 'growth is largely an illusion, driven by fraudulent schemes and illegal tactics deliberately aimed at exploiting Medicaid and Medicare systems to artificially inflate revenue.' On this news, On this news, GeneDx's stock fell $4.84 per share, or 6.7%, to close at $67.18 per share on February 5, 2025. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ——————————- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected]
Yahoo
4 hours ago
- Yahoo
Oscar Health (OSCR) Skyrockets 52% W/W. Time to Take Profits?
Oscar Health, Inc. (NYSE:OSCR) is one of the . Oscar Health jumped by 52 percent week-on-week, finishing at $21.22 versus the $13.95 on June 13, with analysts naming it a meme stock amid the lack of clear catalysts to boost buying appetite. Last week's shortened trading saw Oscar Health, Inc. (NYSE:OSCR) trade higher for four consecutive days, reflecting strong investor confidence amid macroeconomic uncertainties. Additionally, sentiment may have been supported by a new proposal for the Medicare Advantage, called 'Part E,' that would allow individuals and employers to enroll voluntarily. While this would heighten competition with private insurers, the voluntary enrollment could potentially delay or prevent Medicare's sooner-than-expected insolvency, and indirectly benefit Oscar Health, Inc. (NYSE:OSCR) and other private insurers. A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
12 hours ago
- CNBC
6 stocks to buy for the second half, according to Wall Street analysts
Analysts on Wall Street are especially optimistic on a handful of stocks heading into the second half of the year. Equities have been volatile for much of the first half of 2025, as President Donald Trump's tariffs simultaneously sparked investor concern over a potential U.S. recession and higher inflation. Worries over the size of the federal deficit and increasing debt arose from the president's tax bill working its way through Congress. So far in June, the S & P 500 is higher by about 1% after climbing more than 6% in May. There could be more volatility ahead the rest of the month after the U.S. bombed three nuclear sites in Iran over the weekend. For the year, the S & P 500 is up less than 2% as of Friday's close, while the Nasdaq Composite has gained less than 1% and the Dow Jones Industrial Average is showing a 0.8% loss. Looking for potential winning stocks in the second half, CNBC Pro screened for companies where analysts are growing more bullish, using the following criteria: Each stock is part of the S & P 1500 (large cap, mid cap, and small cap) A market cap of at least $1 billion Rated buy by at least 65% of analysts Consensus price target calls for upside of 30% or more Coverage by at least 15 analysts First Solar made the list. Shares have pulled back 18% in 2025. TD Cowen analyst Jeff Osborne called First Solar a "technology leader in solar panel production," pointing to what he said are the company's "advantages of the excess output relative to silicon panels in high temperature/high humidity environments" in a June 12 note. FSLR YTD mountain First Solar stock in 2025. "First Solar continues to lead the pack in thin film efficiencies and in recent years the company has increased its efficiency at a rate 4x faster than multi-crystalline solar panels out of China," Osborne added. TD Cowen rates First Solar a buy and Osborne's $200 per share price target implies 38% upside from Friday's $145.00 close. About 80% of analysts polled by FactSet rate First Solar a buy, with their consensus price target implying roughly the same upside as Osborne. Customer relations management software maker Salesforce stock also appeared on the screen. CEO Marc Benioff's company has slumped 22% so far this year. Cantor analyst Matthew VanVliet named Salesforce one of the biggest near-term beneficiaries in application software, thanks to "further unlocking AI utilization and monetization." VanVliet's $325 per share price target would see the stock rallying 25% from Friday's $260.63 close. CRM YTD mountain Salesforce stock in 2025. Roughly 81% of analysts surveyed by FactSet have a buy rating on Salesforce, but their consensus 12-month price target would amount to even more upside — 35% over the next year. Other companies that Wall Street likes in the second half are BioMarin Pharmaceutical , Light & Wonder , Fiserv and Burlington Stores .
